Mannose binding lectin levels in spondyloarthropathies

Sibel Zehra Aydin1, Pamir Atagunduz, Nevsun Inanc

  • 1Department of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey. drsibelaydin@gmail.com

The Journal of Rheumatology
|September 28, 2007
PubMed
Abstract

Insights

Mannose-binding lectin (MBL) deficiency did not differ between ankylosing spondylitis (AS) patients and controls. However, MBL deficiency showed a trend towards more severe spinal radiographic progression in AS patients.

Area of Science:

  • Immunology
  • Rheumatology
  • Genetics

Background:

  • Mannose-binding lectin (MBL) is a key component of the innate immune system, and MBL deficiency increases infection susceptibility.
  • Gastrointestinal and genitourinary infections are implicated as potential triggers for spondyloarthropathies (SpA).

Purpose of the Study:

  • To investigate the prevalence of MBL deficiency in ankylosing spondylitis (AS) and undifferentiated SpA (uSpA).
  • To explore the association between MBL deficiency and disease severity in AS.

Main Methods:

  • Studied 107 AS patients, 43 uSpA patients, and 74 healthy controls.
  • Measured MBL levels using ELISA kits.
  • Assessed disease activity, radiological scores, and demographic data.

Main Results:

  • No significant differences in median MBL levels or MBL deficiency prevalence were found between AS, uSpA, and control groups.
  • MBL levels did not correlate with Bath AS Radiological Index scores.
  • AS patients with MBL deficiency exhibited a trend towards higher radiographic damage (mSASSS), approximately three times greater, though not statistically significant.

Conclusions:

  • MBL deficiency did not significantly impact disease activity or clinical features in AS patients.
  • A tendency towards more severe radiographic spinal progression, as measured by mSASSS, was observed in AS patients with MBL deficiency.

Related Concept Videos